MIRUSCONE ABUTMENT SYSTEM

Abutment, Implant, Dental, Endosseous

NOBELPHARMA USA, INC.

The following data is part of a premarket notification filed by Nobelpharma Usa, Inc. with the FDA for Miruscone Abutment System.

Pre-market Notification Details

Device IDK961728
510k NumberK961728
Device Name:MIRUSCONE ABUTMENT SYSTEM
ClassificationAbutment, Implant, Dental, Endosseous
Applicant NOBELPHARMA USA, INC. 777 OAKMONT LN. SUITE 100 Westmont,  IL  60559
ContactMary Edwards
CorrespondentMary Edwards
NOBELPHARMA USA, INC. 777 OAKMONT LN. SUITE 100 Westmont,  IL  60559
Product CodeNHA  
CFR Regulation Number872.3630 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1996-05-03
Decision Date1996-07-10
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
07332747017748 K961728 000
07332747003437 K961728 000
07332747003444 K961728 000
07332747003505 K961728 000
07332747003512 K961728 000
07332747003529 K961728 000
07332747017670 K961728 000
07332747017687 K961728 000
07332747017694 K961728 000
07332747017724 K961728 000
07332747017731 K961728 000
07332747003420 K961728 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.